Horizon Solutions

Horizon Discovery is a leading life science company specializing in gene editing and gene modulation technologies, including CRISPR, RNAi, and base editing. The company provides an extensive portfolio of tools and services, such as engineered cell lines, functional genomic screening, and bioproduction solutions, to support drug discovery and development. Its proprietary CHOSource platform is widely used by pharmaceutical and biotech companies for the expression of complex biotherapeutics. Headquartered in Cambridge, UK, Horizon Discovery was acquired by PerkinElmer (now Revvity) in 2020 for approximately $383 million. The company's solutions are integral to identifying genetic drivers of disease and validating novel therapeutic targets across various indications, particularly in oncology and rare diseases.